Evidence map›Paper›PMID 26147502›Full record

ArticlePloS one2015

Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.

Erin Crossey, Kathryn Frietze, David L Narum, David S Peabody, Bryce Chackerian

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Erin CrosseyDepartment of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, United States of America.
Kathryn FrietzeDepartment of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, United States of America.
David L NarumLaboratory of Malaria Immunology and Vaccinology, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, United States of America.
David S PeabodyDepartment of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, United States of America.
Bryce ChackerianDepartment of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque, NM 87131, United States of America.
University of New Mexico · USNational Institute of Allergy and Infectious Diseases · US

Funding

Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
A VLP-based platform for Vaccine DiscoveryR01AI083305 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CHACKERIAN, BRYCE C · 2010 to 2013
$1.2M
Intramural NIH HHSNIAID NIH HHS R01 AI083305NIAID NIH HHS T32 AI007538
6 · The paper itself

Abstract

We have developed a peptide display platform based on VLPs of the RNA bacteriophage MS2 that combines the high immunogenicity of VLP display with affinity selection capabilities. Random peptides can be displayed on the VLP surface by genetically inserting sequences into a surface-exposed loop of the viral coat protein. VLP-displayed peptides can then be isolated by selection using antibodies, and the VLP selectants can then be used directly as immunogens. Here, we investigated the ability of this platform to identify mimotopes of a highly conserved conformational epitope present on the Plasmodium falciparum blood-stage protein AMA1. Using 4G2, a monoclonal antibody that binds to this epitope and is a potent inhibitor of erythrocyte invasion, we screened three different VLP-peptide libraries and identified specific VLPs that bound strongly to the selecting mAb. We then tested the ability of a handful of selected VLPs to elicit anti-AMA1 antibody responses in mice. Most of the selected VLPs failed to reliably elicit AMA1 specific antibodies. However, one VLP consistently induced antibodies that cross-reacted with AMA1. Surprisingly, this VLP bound to 4G2 more weakly than the other selectants we identified. Taken together, these data demonstrate that VLP-peptide display can identify immunogenic mimics of a complex conformational epitope and illustrate the promise and challenges of this approach.

Indexed as

LevivirusPeptide LibraryAmino Acid SequenceAnimalsAntibodies, MonoclonalAntibodies, ProtozoanAntibody AffinityAntigen-Antibody ReactionsAntigens, ProtozoanAntigens, SurfaceChromatography, GelCross ReactionsDimerizationEnzyme-Linked Immunosorbent AssayEpitopesMalaria VaccinesAntibodies, MonoclonalAntibodies, ProtozoanAntigens, ProtozoanAntigens, Surfaceapical membrane antigen I, PlasmodiumEpitopesMalaria VaccinesMembrane ProteinsPeptide LibraryPeptidesProtozoan ProteinsVaccines, Virus-Like Particle

Identifiers

PMID26147502
PMCPMC4493041
OpenAlexW852950976

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.